Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
Rollins School of Public Health, Emory University, Atlanta, Georgia.
Head Neck. 2019 Sep;41(9):3056-3063. doi: 10.1002/hed.25791. Epub 2019 May 2.
Pathologic extranodal extension (ENE) has traditionally guided the management of head and neck cancers. The prognostic value of radiographic ENE (rENE) in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (HPV + OPX) is uncertain.
Patients with HPV + OPX with adequate pretreatment radiographic nodal evaluation from a single institution were analyzed. rENE status was determined by neuroradiologists' at time of diagnosis. Distant metastasis-free survival (DMFS), overall survival (OS), and locoregional recurrence-free survival (LRFS) were estimated using Kaplan-Meier methods. Cox proportional hazards models were fit to assess the impact of rENE on survival endpoints.
Hundred sixty-eight patients with OPX + squamous cell carcinomas diagnosed between April 2008 and December 2014 were included for analysis with median follow-up of 3.3 years. Eighty-eight percent of patients received concurrent chemoradiotherapy. rENE was not prognostic; its presence in patients with HPV + OPX did not significantly impact OS, LRFS, or DMFS.
In patients with HPV + OPX, rENE was not significantly associated with OS, LRFS, or DMFS.
病理性结外扩展(ENE)传统上指导头颈部癌症的治疗。人乳头瘤病毒(HPV)相关口咽鳞状细胞癌(HPV+OPX)中放射性 ENE(rENE)的预后价值尚不确定。
分析了来自单一机构的 HPV+OPX 患者,这些患者具有充分的预处理放射性淋巴结评估。rENE 状态由神经放射科医生在诊断时确定。通过 Kaplan-Meier 方法估计无远处转移生存率(DMFS)、总生存率(OS)和局部区域无复发生存率(LRFS)。使用 Cox 比例风险模型评估 rENE 对生存终点的影响。
纳入了 168 例 2008 年 4 月至 2014 年 12 月诊断的 OPX+鳞状细胞癌患者进行分析,中位随访时间为 3.3 年。88%的患者接受了同期放化疗。rENE 没有预后意义;其存在于 HPV+OPX 患者中与 OS、LRFS 或 DMFS 无显著相关性。
在 HPV+OPX 患者中,rENE 与 OS、LRFS 或 DMFS 无显著相关性。